The Transformation Matrix: Structural Relationships and Literature

What this page is and is not

The operator source documents present a conversion matrix with a "method" column. This page presents the same matrix with that column removed and replaced by two others: the structural change, stated in the abstract, and the literature in which the chemistry is documented. The reason is not squeamishness about the subject. It is that the useful content of a conversion matrix, for a researcher, an analyst, a processor managing stability or a regulator reading a policy brief, is entirely contained in the structural relationship and the reference. The procedural content adds nothing to any of those tasks and is the one part of the material that this shelf will not carry. So: no reagents, no catalysts, no solvents, no equivalents, no temperatures, no times, no work-ups, no yields, and no numbered steps. Where a procedure exists, the citation is named and the procedure is not described.

Sources: Van Kush Family Research Institute 2026* · Van Kush Family Research Institute 2026*

Group A — passive and degradative conversions

These happen whether anyone wants them to or not. They are what a stability study measures, what a storage protocol is designed against, and what a certificate of analysis implicitly reports the accumulated result of. The single most important is the oxidation of Δ9-THC to CBN, in which the terpenoid ring is aromatised, the two stereocentres are destroyed, and CB1 affinity falls substantially. It is driven by oxygen, accelerated by light and heat, and proceeds continuously over time; long-term stability work on cannabis resin and extracts shows THC declining and CBN rising together, and kinetic studies have characterised the temperature and pH dependence. Alongside it sit the photochemical closure of the CBC chromene into the strained cyclobutane of CBL, the epoxidation-and-rearrangement route from the CBD and THC types to the CBE type, and the slow drift of the Δ9 alkene toward the more stable Δ8 position. The general lesson is worth stating as a principle: a cannabinoid profile is a clock. The THC-to-CBN ratio, the presence of CBL, the appearance of CBE and the Δ8-to-Δ9 ratio are all records of how much oxygen, light, heat and time a sample has seen, and they can be read as such.

Sources: Lindholst C 2010 · Jaidee W 2022 · Hanuš LO 2016 · Radwan MM 2021

Group B — deliberate chemical conversions, as structure and literature only

Three deliberate transformations account for most of the commercially relevant novel-cannabinoid landscape, and they are three different kinds of chemistry with three different difficulty levels. The first is ring closure: the open resorcinol-and-terpene arrangement of the CBD type cyclises to the closed pyran of the THC type under acid catalysis, with no change in molecular formula. This was first reported by Adams and co-workers in 1940 and 1941, revisited by Gaoni and Mechoulam in 1966, reviewed comprehensively by Bloemendal and colleagues in 2020, studied for its regiochemistry by Marzullo and colleagues in the same year, and is the subject of a granted United States patent. The relevant fact for a regulatory analysis is not any procedural detail but the single word facile: the transformation is chemically easy, it has been in the open literature for eighty-five years, and the product distribution of uncontrolled versions of it has been characterised in the forensic literature. The second is side-chain homologation, which is a different and harder class of transformation because it modifies the alkyl chain rather than closing a ring — it changes the carbon count instead of rearranging the existing atoms, and that is why the C6, C7 and C8 series are not reachable by the same chemistry as Δ8. The third is acylation of the free phenol to give an ester, of which THC-O-acetate is the example that reached the market.

Sources: Adams R 1940 · Adams R 1941 · Gaoni Y 1966 · Bloemendal VRLJ 2020 · Marzullo P 2020 · Kiselak TD 2020 · Webster GRB 2008 · Razdan RK 1974 · Crombie L 1988

The matrix

Sources: Lindholst C 2010 · Jaidee W 2022 · Hanuš LO 2016 · Radwan MM 2021 · Adams R 1940 · Adams R 1941 · Gaoni Y 1966 · Marzullo P 2020 · Bloemendal VRLJ 2020 · Webster GRB 2008 · Kiselak TD 2020 · Citti C 2019 · Razdan RK 1974 · Crombie L 1988 · Munger KR 2022 · Wang M 2016 · Filer CN 2022

The acetate ester hazard: ketene in vitro

This one is a genuine harm-reduction point and it belongs stated plainly rather than buried in the matrix. Acetylating the free phenol of a cannabinoid gives an acetate ester — THC-O-acetate is the case that reached the market — which is pharmacologically inert as such and depends on esterases cleaving it after absorption to release the parent cannabinoid. The hazard is not in that mechanism, it is in what the ester does when heated. Acetate esters of this kind share a substructure with vitamin E acetate, the compound implicated in the 2019 outbreak of vaping-associated lung injury, and the same thermal chemistry applies: heating can eliminate ketene, a highly reactive gas with a documented history as a pulmonary toxicant. Munger, Jensen and Strongin tested this directly, vaping Δ8-THC acetate, CBN acetate and CBD acetate under realistic conditions plus a commercial Δ8-THC acetate product bought online, and found ketene in the condensate from all of them. The relative amounts they report are informative: taking Δ8-THC-O-acetate as 1.0, the CBD diacetate produced about 13 times as much and CBN acetate about 3.6 times as much, which tracks the number of acetate groups available. The practical statement is that an acetylated cannabinoid intended for inhalation carries a specific, mechanistically understood and experimentally confirmed hazard that the parent cannabinoid does not, and that this is a property of the ester rather than of any particular manufacturer.

Sources: Munger KR 2022

Why the ring-closure chemistry is the fact regulatory analysis turns on

CBD and Δ9-THC have the same molecular formula and differ by one ring closure that has been documented in the open chemical literature since 1940, is the subject of a granted patent, and has been reviewed as a synthetic pathway in a mainstream organic chemistry journal. The operator brief builds its policy argument on that observation, and the observation itself is correct and well sourced. Two things should be said alongside it. The chemistry being easy is a statement about chemistry, not a recommendation, and the forensic literature on uncontrolled conversion is a catalogue of why: the product is a mixture whose composition depends on conditions, containing positional isomers, alternative ring closures and further reaction products, most of which have no pharmacology or toxicology in the literature and several of which have no reference standards. Unidentified isomers in an inhaled or ingested product are the concrete harm, and that harm is an argument for analytical requirements and honest certificates rather than for either prohibition or silence.

Sources: Kiselak TD 2020 · Bloemendal VRLJ 2020 · Marzullo P 2020 · Webster GRB 2008 · Van Kush Family Research Institute 2026*